Global Radiotheranostic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Radiotheranostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiotheranostic players cover ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc. and Curium SAS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Radiotheranostic Industry Forecast” looks at past sales and reviews total world Radiotheranostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiotheranostic sales for 2023 through 2029. With Radiotheranostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiotheranostic industry.
This Insight Report provides a comprehensive analysis of the global Radiotheranostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiotheranostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiotheranostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiotheranostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiotheranostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiotheranostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Radiotheranostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiotheranostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiotheranostic players cover ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc. and Curium SAS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Radiotheranostic Industry Forecast” looks at past sales and reviews total world Radiotheranostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiotheranostic sales for 2023 through 2029. With Radiotheranostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiotheranostic industry.
This Insight Report provides a comprehensive analysis of the global Radiotheranostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiotheranostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiotheranostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiotheranostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiotheranostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiotheranostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Nuclear Reactors
- Cyclotrons
- Oncology
- Non-Oncology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ITM Isotopen Technologien M?nchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Clarity Pharmaceuticals.
- TransCode Therapeutics, Inc.
- Curium SAS
- GE Healthcare Inc.
- Bayer AG
- Lantheus Medical
- Imaging, Inc.
- Novartis AG
- Spectrum Pharmaceuticals, Inc.
- Ipsen S.A.
- Actinium Pharmaceuticals, Inc. (ATNM)
- Nordic Nanovector ASA
- Y-mAbs Therapeutics, Inc.
- Sofie Biosciences, Inc.
- Terumo Corporation
- Sirtex Medical Limited
- Boston Scientific Corporation
- Nihon Medi-Physics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiotheranostic Market Size 2018-2029
2.1.2 Radiotheranostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radiotheranostic Segment by Type
2.2.1 Nuclear Reactors
2.2.2 Cyclotrons
2.3 Radiotheranostic Market Size by Type
2.3.1 Radiotheranostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radiotheranostic Market Size Market Share by Type (2018-2023)
2.4 Radiotheranostic Segment by Application
2.4.1 Oncology
2.4.2 Non-Oncology
2.5 Radiotheranostic Market Size by Application
2.5.1 Radiotheranostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radiotheranostic Market Size Market Share by Application (2018-2023)
3 RADIOTHERANOSTIC MARKET SIZE BY PLAYER
3.1 Radiotheranostic Market Size Market Share by Players
3.1.1 Global Radiotheranostic Revenue by Players (2018-2023)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2018-2023)
3.2 Global Radiotheranostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOTHERANOSTIC BY REGIONS
4.1 Radiotheranostic Market Size by Regions (2018-2023)
4.2 Americas Radiotheranostic Market Size Growth (2018-2023)
4.3 APAC Radiotheranostic Market Size Growth (2018-2023)
4.4 Europe Radiotheranostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Radiotheranostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radiotheranostic Market Size by Country (2018-2023)
5.2 Americas Radiotheranostic Market Size by Type (2018-2023)
5.3 Americas Radiotheranostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiotheranostic Market Size by Region (2018-2023)
6.2 APAC Radiotheranostic Market Size by Type (2018-2023)
6.3 APAC Radiotheranostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiotheranostic by Country (2018-2023)
7.2 Europe Radiotheranostic Market Size by Type (2018-2023)
7.3 Europe Radiotheranostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiotheranostic by Region (2018-2023)
8.2 Middle East & Africa Radiotheranostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Radiotheranostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOTHERANOSTIC MARKET FORECAST
10.1 Global Radiotheranostic Forecast by Regions (2024-2029)
10.1.1 Global Radiotheranostic Forecast by Regions (2024-2029)
10.1.2 Americas Radiotheranostic Forecast
10.1.3 APAC Radiotheranostic Forecast
10.1.4 Europe Radiotheranostic Forecast
10.1.5 Middle East & Africa Radiotheranostic Forecast
10.2 Americas Radiotheranostic Forecast by Country (2024-2029)
10.2.1 United States Radiotheranostic Market Forecast
10.2.2 Canada Radiotheranostic Market Forecast
10.2.3 Mexico Radiotheranostic Market Forecast
10.2.4 Brazil Radiotheranostic Market Forecast
10.3 APAC Radiotheranostic Forecast by Region (2024-2029)
10.3.1 China Radiotheranostic Market Forecast
10.3.2 Japan Radiotheranostic Market Forecast
10.3.3 Korea Radiotheranostic Market Forecast
10.3.4 Southeast Asia Radiotheranostic Market Forecast
10.3.5 India Radiotheranostic Market Forecast
10.3.6 Australia Radiotheranostic Market Forecast
10.4 Europe Radiotheranostic Forecast by Country (2024-2029)
10.4.1 Germany Radiotheranostic Market Forecast
10.4.2 France Radiotheranostic Market Forecast
10.4.3 UK Radiotheranostic Market Forecast
10.4.4 Italy Radiotheranostic Market Forecast
10.4.5 Russia Radiotheranostic Market Forecast
10.5 Middle East & Africa Radiotheranostic Forecast by Region (2024-2029)
10.5.1 Egypt Radiotheranostic Market Forecast
10.5.2 South Africa Radiotheranostic Market Forecast
10.5.3 Israel Radiotheranostic Market Forecast
10.5.4 Turkey Radiotheranostic Market Forecast
10.5.5 GCC Countries Radiotheranostic Market Forecast
10.6 Global Radiotheranostic Forecast by Type (2024-2029)
10.7 Global Radiotheranostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 ITM Isotopen Technologien M?nchen AG
11.1.1 ITM Isotopen Technologien M?nchen AG Company Information
11.1.2 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
11.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 ITM Isotopen Technologien M?nchen AG Main Business Overview
11.1.5 ITM Isotopen Technologien M?nchen AG Latest Developments
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Information
11.2.2 Advanced Accelerator Applications Radiotheranostic Product Offered
11.2.3 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Advanced Accelerator Applications Main Business Overview
11.2.5 Advanced Accelerator Applications Latest Developments
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Information
11.3.2 Telix Pharmaceuticals Radiotheranostic Product Offered
11.3.3 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Telix Pharmaceuticals Main Business Overview
11.3.5 Telix Pharmaceuticals Latest Developments
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Information
11.4.2 Theragnostics Ltd. Radiotheranostic Product Offered
11.4.3 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Theragnostics Ltd. Main Business Overview
11.4.5 Theragnostics Ltd. Latest Developments
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Information
11.5.2 NuView Life Sciences Radiotheranostic Product Offered
11.5.3 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 NuView Life Sciences Main Business Overview
11.5.5 NuView Life Sciences Latest Developments
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Information
11.6.2 Jubilant Pharma Limited Radiotheranostic Product Offered
11.6.3 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Jubilant Pharma Limited Main Business Overview
11.6.5 Jubilant Pharma Limited Latest Developments
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Information
11.7.2 Clarity Pharmaceuticals. Radiotheranostic Product Offered
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Clarity Pharmaceuticals. Main Business Overview
11.7.5 Clarity Pharmaceuticals. Latest Developments
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Information
11.8.2 TransCode Therapeutics, Inc. Radiotheranostic Product Offered
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TransCode Therapeutics, Inc. Main Business Overview
11.8.5 TransCode Therapeutics, Inc. Latest Developments
11.9 Curium SAS
11.9.1 Curium SAS Company Information
11.9.2 Curium SAS Radiotheranostic Product Offered
11.9.3 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Curium SAS Main Business Overview
11.9.5 Curium SAS Latest Developments
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Information
11.10.2 GE Healthcare Inc. Radiotheranostic Product Offered
11.10.3 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 GE Healthcare Inc. Main Business Overview
11.10.5 GE Healthcare Inc. Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radiotheranostic Product Offered
11.11.3 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Information
11.12.2 Lantheus Medical Radiotheranostic Product Offered
11.12.3 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Lantheus Medical Main Business Overview
11.12.5 Lantheus Medical Latest Developments
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Information
11.13.2 Imaging, Inc. Radiotheranostic Product Offered
11.13.3 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Imaging, Inc. Main Business Overview
11.13.5 Imaging, Inc. Latest Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Information
11.14.2 Novartis AG Radiotheranostic Product Offered
11.14.3 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Novartis AG Main Business Overview
11.14.5 Novartis AG Latest Developments
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Information
11.15.2 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.15.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Information
11.16.2 Ipsen S.A. Radiotheranostic Product Offered
11.16.3 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Ipsen S.A. Main Business Overview
11.16.5 Ipsen S.A. Latest Developments
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Information
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Main Business Overview
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Information
11.18.2 Nordic Nanovector ASA Radiotheranostic Product Offered
11.18.3 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Nordic Nanovector ASA Main Business Overview
11.18.5 Nordic Nanovector ASA Latest Developments
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Information
11.19.2 Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Y-mAbs Therapeutics, Inc. Main Business Overview
11.19.5 Y-mAbs Therapeutics, Inc. Latest Developments
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Information
11.20.2 Sofie Biosciences, Inc. Radiotheranostic Product Offered
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Sofie Biosciences, Inc. Main Business Overview
11.20.5 Sofie Biosciences, Inc. Latest Developments
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Information
11.21.2 Terumo Corporation Radiotheranostic Product Offered
11.21.3 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Terumo Corporation Main Business Overview
11.21.5 Terumo Corporation Latest Developments
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Information
11.22.2 Sirtex Medical Limited Radiotheranostic Product Offered
11.22.3 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Sirtex Medical Limited Main Business Overview
11.22.5 Sirtex Medical Limited Latest Developments
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Information
11.23.2 Boston Scientific Corporation Radiotheranostic Product Offered
11.23.3 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Boston Scientific Corporation Main Business Overview
11.23.5 Boston Scientific Corporation Latest Developments
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Information
11.24.2 Nihon Medi-Physics Radiotheranostic Product Offered
11.24.3 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nihon Medi-Physics Main Business Overview
11.24.5 Nihon Medi-Physics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiotheranostic Market Size 2018-2029
2.1.2 Radiotheranostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radiotheranostic Segment by Type
2.2.1 Nuclear Reactors
2.2.2 Cyclotrons
2.3 Radiotheranostic Market Size by Type
2.3.1 Radiotheranostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radiotheranostic Market Size Market Share by Type (2018-2023)
2.4 Radiotheranostic Segment by Application
2.4.1 Oncology
2.4.2 Non-Oncology
2.5 Radiotheranostic Market Size by Application
2.5.1 Radiotheranostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radiotheranostic Market Size Market Share by Application (2018-2023)
3 RADIOTHERANOSTIC MARKET SIZE BY PLAYER
3.1 Radiotheranostic Market Size Market Share by Players
3.1.1 Global Radiotheranostic Revenue by Players (2018-2023)
3.1.2 Global Radiotheranostic Revenue Market Share by Players (2018-2023)
3.2 Global Radiotheranostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOTHERANOSTIC BY REGIONS
4.1 Radiotheranostic Market Size by Regions (2018-2023)
4.2 Americas Radiotheranostic Market Size Growth (2018-2023)
4.3 APAC Radiotheranostic Market Size Growth (2018-2023)
4.4 Europe Radiotheranostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Radiotheranostic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radiotheranostic Market Size by Country (2018-2023)
5.2 Americas Radiotheranostic Market Size by Type (2018-2023)
5.3 Americas Radiotheranostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiotheranostic Market Size by Region (2018-2023)
6.2 APAC Radiotheranostic Market Size by Type (2018-2023)
6.3 APAC Radiotheranostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiotheranostic by Country (2018-2023)
7.2 Europe Radiotheranostic Market Size by Type (2018-2023)
7.3 Europe Radiotheranostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiotheranostic by Region (2018-2023)
8.2 Middle East & Africa Radiotheranostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Radiotheranostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOTHERANOSTIC MARKET FORECAST
10.1 Global Radiotheranostic Forecast by Regions (2024-2029)
10.1.1 Global Radiotheranostic Forecast by Regions (2024-2029)
10.1.2 Americas Radiotheranostic Forecast
10.1.3 APAC Radiotheranostic Forecast
10.1.4 Europe Radiotheranostic Forecast
10.1.5 Middle East & Africa Radiotheranostic Forecast
10.2 Americas Radiotheranostic Forecast by Country (2024-2029)
10.2.1 United States Radiotheranostic Market Forecast
10.2.2 Canada Radiotheranostic Market Forecast
10.2.3 Mexico Radiotheranostic Market Forecast
10.2.4 Brazil Radiotheranostic Market Forecast
10.3 APAC Radiotheranostic Forecast by Region (2024-2029)
10.3.1 China Radiotheranostic Market Forecast
10.3.2 Japan Radiotheranostic Market Forecast
10.3.3 Korea Radiotheranostic Market Forecast
10.3.4 Southeast Asia Radiotheranostic Market Forecast
10.3.5 India Radiotheranostic Market Forecast
10.3.6 Australia Radiotheranostic Market Forecast
10.4 Europe Radiotheranostic Forecast by Country (2024-2029)
10.4.1 Germany Radiotheranostic Market Forecast
10.4.2 France Radiotheranostic Market Forecast
10.4.3 UK Radiotheranostic Market Forecast
10.4.4 Italy Radiotheranostic Market Forecast
10.4.5 Russia Radiotheranostic Market Forecast
10.5 Middle East & Africa Radiotheranostic Forecast by Region (2024-2029)
10.5.1 Egypt Radiotheranostic Market Forecast
10.5.2 South Africa Radiotheranostic Market Forecast
10.5.3 Israel Radiotheranostic Market Forecast
10.5.4 Turkey Radiotheranostic Market Forecast
10.5.5 GCC Countries Radiotheranostic Market Forecast
10.6 Global Radiotheranostic Forecast by Type (2024-2029)
10.7 Global Radiotheranostic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 ITM Isotopen Technologien M?nchen AG
11.1.1 ITM Isotopen Technologien M?nchen AG Company Information
11.1.2 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
11.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 ITM Isotopen Technologien M?nchen AG Main Business Overview
11.1.5 ITM Isotopen Technologien M?nchen AG Latest Developments
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Information
11.2.2 Advanced Accelerator Applications Radiotheranostic Product Offered
11.2.3 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Advanced Accelerator Applications Main Business Overview
11.2.5 Advanced Accelerator Applications Latest Developments
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Information
11.3.2 Telix Pharmaceuticals Radiotheranostic Product Offered
11.3.3 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Telix Pharmaceuticals Main Business Overview
11.3.5 Telix Pharmaceuticals Latest Developments
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Information
11.4.2 Theragnostics Ltd. Radiotheranostic Product Offered
11.4.3 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Theragnostics Ltd. Main Business Overview
11.4.5 Theragnostics Ltd. Latest Developments
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Information
11.5.2 NuView Life Sciences Radiotheranostic Product Offered
11.5.3 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 NuView Life Sciences Main Business Overview
11.5.5 NuView Life Sciences Latest Developments
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Information
11.6.2 Jubilant Pharma Limited Radiotheranostic Product Offered
11.6.3 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Jubilant Pharma Limited Main Business Overview
11.6.5 Jubilant Pharma Limited Latest Developments
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Information
11.7.2 Clarity Pharmaceuticals. Radiotheranostic Product Offered
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Clarity Pharmaceuticals. Main Business Overview
11.7.5 Clarity Pharmaceuticals. Latest Developments
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Information
11.8.2 TransCode Therapeutics, Inc. Radiotheranostic Product Offered
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TransCode Therapeutics, Inc. Main Business Overview
11.8.5 TransCode Therapeutics, Inc. Latest Developments
11.9 Curium SAS
11.9.1 Curium SAS Company Information
11.9.2 Curium SAS Radiotheranostic Product Offered
11.9.3 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Curium SAS Main Business Overview
11.9.5 Curium SAS Latest Developments
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Information
11.10.2 GE Healthcare Inc. Radiotheranostic Product Offered
11.10.3 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 GE Healthcare Inc. Main Business Overview
11.10.5 GE Healthcare Inc. Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radiotheranostic Product Offered
11.11.3 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Information
11.12.2 Lantheus Medical Radiotheranostic Product Offered
11.12.3 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Lantheus Medical Main Business Overview
11.12.5 Lantheus Medical Latest Developments
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Information
11.13.2 Imaging, Inc. Radiotheranostic Product Offered
11.13.3 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Imaging, Inc. Main Business Overview
11.13.5 Imaging, Inc. Latest Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Information
11.14.2 Novartis AG Radiotheranostic Product Offered
11.14.3 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Novartis AG Main Business Overview
11.14.5 Novartis AG Latest Developments
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Information
11.15.2 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.15.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Information
11.16.2 Ipsen S.A. Radiotheranostic Product Offered
11.16.3 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Ipsen S.A. Main Business Overview
11.16.5 Ipsen S.A. Latest Developments
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Information
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Main Business Overview
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Information
11.18.2 Nordic Nanovector ASA Radiotheranostic Product Offered
11.18.3 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Nordic Nanovector ASA Main Business Overview
11.18.5 Nordic Nanovector ASA Latest Developments
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Information
11.19.2 Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Y-mAbs Therapeutics, Inc. Main Business Overview
11.19.5 Y-mAbs Therapeutics, Inc. Latest Developments
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Information
11.20.2 Sofie Biosciences, Inc. Radiotheranostic Product Offered
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Sofie Biosciences, Inc. Main Business Overview
11.20.5 Sofie Biosciences, Inc. Latest Developments
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Information
11.21.2 Terumo Corporation Radiotheranostic Product Offered
11.21.3 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Terumo Corporation Main Business Overview
11.21.5 Terumo Corporation Latest Developments
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Information
11.22.2 Sirtex Medical Limited Radiotheranostic Product Offered
11.22.3 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Sirtex Medical Limited Main Business Overview
11.22.5 Sirtex Medical Limited Latest Developments
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Information
11.23.2 Boston Scientific Corporation Radiotheranostic Product Offered
11.23.3 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Boston Scientific Corporation Main Business Overview
11.23.5 Boston Scientific Corporation Latest Developments
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Information
11.24.2 Nihon Medi-Physics Radiotheranostic Product Offered
11.24.3 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nihon Medi-Physics Main Business Overview
11.24.5 Nihon Medi-Physics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiotheranostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nuclear Reactors
Table 3. Major Players of Cyclotrons
Table 4. Radiotheranostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 7. Radiotheranostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 10. Global Radiotheranostic Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Radiotheranostic Revenue Market Share by Player (2018-2023)
Table 12. Radiotheranostic Key Players Head office and Products Offered
Table 13. Radiotheranostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Radiotheranostic Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Radiotheranostic Market Size Market Share by Regions (2018-2023)
Table 18. Global Radiotheranostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Radiotheranostic Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Radiotheranostic Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Radiotheranostic Market Size Market Share by Country (2018-2023)
Table 22. Americas Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 24. Americas Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 26. APAC Radiotheranostic Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Radiotheranostic Market Size Market Share by Region (2018-2023)
Table 28. APAC Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 30. APAC Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 32. Europe Radiotheranostic Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Radiotheranostic Market Size Market Share by Country (2018-2023)
Table 34. Europe Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 36. Europe Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Radiotheranostic Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Radiotheranostic
Table 45. Key Market Challenges & Risks of Radiotheranostic
Table 46. Key Industry Trends of Radiotheranostic
Table 47. Global Radiotheranostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Radiotheranostic Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Radiotheranostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Radiotheranostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. ITM Isotopen Technologien M?nchen AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 52. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
Table 53. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. ITM Isotopen Technologien M?nchen AG Main Business
Table 55. ITM Isotopen Technologien M?nchen AG Latest Developments
Table 56. Advanced Accelerator Applications Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 57. Advanced Accelerator Applications Radiotheranostic Product Offered
Table 58. Advanced Accelerator Applications Main Business
Table 59. Advanced Accelerator Applications Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Advanced Accelerator Applications Latest Developments
Table 61. Telix Pharmaceuticals Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 62. Telix Pharmaceuticals Radiotheranostic Product Offered
Table 63. Telix Pharmaceuticals Main Business
Table 64. Telix Pharmaceuticals Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Telix Pharmaceuticals Latest Developments
Table 66. Theragnostics Ltd. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 67. Theragnostics Ltd. Radiotheranostic Product Offered
Table 68. Theragnostics Ltd. Main Business
Table 69. Theragnostics Ltd. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Theragnostics Ltd. Latest Developments
Table 71. NuView Life Sciences Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 72. NuView Life Sciences Radiotheranostic Product Offered
Table 73. NuView Life Sciences Main Business
Table 74. NuView Life Sciences Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. NuView Life Sciences Latest Developments
Table 76. Jubilant Pharma Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 77. Jubilant Pharma Limited Radiotheranostic Product Offered
Table 78. Jubilant Pharma Limited Main Business
Table 79. Jubilant Pharma Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Jubilant Pharma Limited Latest Developments
Table 81. Clarity Pharmaceuticals. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 82. Clarity Pharmaceuticals. Radiotheranostic Product Offered
Table 83. Clarity Pharmaceuticals. Main Business
Table 84. Clarity Pharmaceuticals. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Clarity Pharmaceuticals. Latest Developments
Table 86. TransCode Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 87. TransCode Therapeutics, Inc. Radiotheranostic Product Offered
Table 88. TransCode Therapeutics, Inc. Main Business
Table 89. TransCode Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. TransCode Therapeutics, Inc. Latest Developments
Table 91. Curium SAS Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 92. Curium SAS Radiotheranostic Product Offered
Table 93. Curium SAS Main Business
Table 94. Curium SAS Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Curium SAS Latest Developments
Table 96. GE Healthcare Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 97. GE Healthcare Inc. Radiotheranostic Product Offered
Table 98. GE Healthcare Inc. Main Business
Table 99. GE Healthcare Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. GE Healthcare Inc. Latest Developments
Table 101. Bayer AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 102. Bayer AG Radiotheranostic Product Offered
Table 103. Bayer AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Bayer AG Main Business
Table 105. Bayer AG Latest Developments
Table 106. Lantheus Medical Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 107. Lantheus Medical Radiotheranostic Product Offered
Table 108. Lantheus Medical Main Business
Table 109. Lantheus Medical Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Lantheus Medical Latest Developments
Table 111. Imaging, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 112. Imaging, Inc. Radiotheranostic Product Offered
Table 113. Imaging, Inc. Main Business
Table 114. Imaging, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Imaging, Inc. Latest Developments
Table 116. Novartis AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 117. Novartis AG Radiotheranostic Product Offered
Table 118. Novartis AG Main Business
Table 119. Novartis AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Novartis AG Latest Developments
Table 121. Spectrum Pharmaceuticals, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 122. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
Table 123. Spectrum Pharmaceuticals, Inc. Main Business
Table 124. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 126. Ipsen S.A. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 127. Ipsen S.A. Radiotheranostic Product Offered
Table 128. Ipsen S.A. Main Business
Table 129. Ipsen S.A. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Ipsen S.A. Latest Developments
Table 131. Actinium Pharmaceuticals, Inc. (ATNM) Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 132. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
Table 133. Actinium Pharmaceuticals, Inc. (ATNM) Main Business
Table 134. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
Table 136. Nordic Nanovector ASA Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 137. Nordic Nanovector ASA Radiotheranostic Product Offered
Table 138. Nordic Nanovector ASA Main Business
Table 139. Nordic Nanovector ASA Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Nordic Nanovector ASA Latest Developments
Table 141. Y-mAbs Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 142. Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
Table 143. Y-mAbs Therapeutics, Inc. Main Business
Table 144. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Y-mAbs Therapeutics, Inc. Latest Developments
Table 146. Sofie Biosciences, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 147. Sofie Biosciences, Inc. Radiotheranostic Product Offered
Table 148. Sofie Biosciences, Inc. Main Business
Table 149. Sofie Biosciences, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Sofie Biosciences, Inc. Latest Developments
Table 151. Terumo Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 152. Terumo Corporation Radiotheranostic Product Offered
Table 153. Terumo Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Terumo Corporation Main Business
Table 155. Terumo Corporation Latest Developments
Table 156. Sirtex Medical Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 157. Sirtex Medical Limited Radiotheranostic Product Offered
Table 158. Sirtex Medical Limited Main Business
Table 159. Sirtex Medical Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Sirtex Medical Limited Latest Developments
Table 161. Boston Scientific Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 162. Boston Scientific Corporation Radiotheranostic Product Offered
Table 163. Boston Scientific Corporation Main Business
Table 164. Boston Scientific Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. Boston Scientific Corporation Latest Developments
Table 166. Nihon Medi-Physics Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 167. Nihon Medi-Physics Radiotheranostic Product Offered
Table 168. Nihon Medi-Physics Main Business
Table 169. Nihon Medi-Physics Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 170. Nihon Medi-Physics Latest Developments
Table 1. Radiotheranostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nuclear Reactors
Table 3. Major Players of Cyclotrons
Table 4. Radiotheranostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 7. Radiotheranostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 10. Global Radiotheranostic Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Radiotheranostic Revenue Market Share by Player (2018-2023)
Table 12. Radiotheranostic Key Players Head office and Products Offered
Table 13. Radiotheranostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Radiotheranostic Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Radiotheranostic Market Size Market Share by Regions (2018-2023)
Table 18. Global Radiotheranostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Radiotheranostic Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Radiotheranostic Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Radiotheranostic Market Size Market Share by Country (2018-2023)
Table 22. Americas Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 24. Americas Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 26. APAC Radiotheranostic Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Radiotheranostic Market Size Market Share by Region (2018-2023)
Table 28. APAC Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 30. APAC Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 32. Europe Radiotheranostic Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Radiotheranostic Market Size Market Share by Country (2018-2023)
Table 34. Europe Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 36. Europe Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Radiotheranostic Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Radiotheranostic Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Radiotheranostic Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Radiotheranostic
Table 45. Key Market Challenges & Risks of Radiotheranostic
Table 46. Key Industry Trends of Radiotheranostic
Table 47. Global Radiotheranostic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Radiotheranostic Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Radiotheranostic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Radiotheranostic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. ITM Isotopen Technologien M?nchen AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 52. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
Table 53. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. ITM Isotopen Technologien M?nchen AG Main Business
Table 55. ITM Isotopen Technologien M?nchen AG Latest Developments
Table 56. Advanced Accelerator Applications Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 57. Advanced Accelerator Applications Radiotheranostic Product Offered
Table 58. Advanced Accelerator Applications Main Business
Table 59. Advanced Accelerator Applications Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Advanced Accelerator Applications Latest Developments
Table 61. Telix Pharmaceuticals Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 62. Telix Pharmaceuticals Radiotheranostic Product Offered
Table 63. Telix Pharmaceuticals Main Business
Table 64. Telix Pharmaceuticals Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Telix Pharmaceuticals Latest Developments
Table 66. Theragnostics Ltd. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 67. Theragnostics Ltd. Radiotheranostic Product Offered
Table 68. Theragnostics Ltd. Main Business
Table 69. Theragnostics Ltd. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Theragnostics Ltd. Latest Developments
Table 71. NuView Life Sciences Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 72. NuView Life Sciences Radiotheranostic Product Offered
Table 73. NuView Life Sciences Main Business
Table 74. NuView Life Sciences Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. NuView Life Sciences Latest Developments
Table 76. Jubilant Pharma Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 77. Jubilant Pharma Limited Radiotheranostic Product Offered
Table 78. Jubilant Pharma Limited Main Business
Table 79. Jubilant Pharma Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Jubilant Pharma Limited Latest Developments
Table 81. Clarity Pharmaceuticals. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 82. Clarity Pharmaceuticals. Radiotheranostic Product Offered
Table 83. Clarity Pharmaceuticals. Main Business
Table 84. Clarity Pharmaceuticals. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Clarity Pharmaceuticals. Latest Developments
Table 86. TransCode Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 87. TransCode Therapeutics, Inc. Radiotheranostic Product Offered
Table 88. TransCode Therapeutics, Inc. Main Business
Table 89. TransCode Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. TransCode Therapeutics, Inc. Latest Developments
Table 91. Curium SAS Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 92. Curium SAS Radiotheranostic Product Offered
Table 93. Curium SAS Main Business
Table 94. Curium SAS Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Curium SAS Latest Developments
Table 96. GE Healthcare Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 97. GE Healthcare Inc. Radiotheranostic Product Offered
Table 98. GE Healthcare Inc. Main Business
Table 99. GE Healthcare Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. GE Healthcare Inc. Latest Developments
Table 101. Bayer AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 102. Bayer AG Radiotheranostic Product Offered
Table 103. Bayer AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Bayer AG Main Business
Table 105. Bayer AG Latest Developments
Table 106. Lantheus Medical Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 107. Lantheus Medical Radiotheranostic Product Offered
Table 108. Lantheus Medical Main Business
Table 109. Lantheus Medical Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Lantheus Medical Latest Developments
Table 111. Imaging, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 112. Imaging, Inc. Radiotheranostic Product Offered
Table 113. Imaging, Inc. Main Business
Table 114. Imaging, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Imaging, Inc. Latest Developments
Table 116. Novartis AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 117. Novartis AG Radiotheranostic Product Offered
Table 118. Novartis AG Main Business
Table 119. Novartis AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Novartis AG Latest Developments
Table 121. Spectrum Pharmaceuticals, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 122. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
Table 123. Spectrum Pharmaceuticals, Inc. Main Business
Table 124. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 126. Ipsen S.A. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 127. Ipsen S.A. Radiotheranostic Product Offered
Table 128. Ipsen S.A. Main Business
Table 129. Ipsen S.A. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Ipsen S.A. Latest Developments
Table 131. Actinium Pharmaceuticals, Inc. (ATNM) Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 132. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
Table 133. Actinium Pharmaceuticals, Inc. (ATNM) Main Business
Table 134. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
Table 136. Nordic Nanovector ASA Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 137. Nordic Nanovector ASA Radiotheranostic Product Offered
Table 138. Nordic Nanovector ASA Main Business
Table 139. Nordic Nanovector ASA Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Nordic Nanovector ASA Latest Developments
Table 141. Y-mAbs Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 142. Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
Table 143. Y-mAbs Therapeutics, Inc. Main Business
Table 144. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Y-mAbs Therapeutics, Inc. Latest Developments
Table 146. Sofie Biosciences, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 147. Sofie Biosciences, Inc. Radiotheranostic Product Offered
Table 148. Sofie Biosciences, Inc. Main Business
Table 149. Sofie Biosciences, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Sofie Biosciences, Inc. Latest Developments
Table 151. Terumo Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 152. Terumo Corporation Radiotheranostic Product Offered
Table 153. Terumo Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Terumo Corporation Main Business
Table 155. Terumo Corporation Latest Developments
Table 156. Sirtex Medical Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 157. Sirtex Medical Limited Radiotheranostic Product Offered
Table 158. Sirtex Medical Limited Main Business
Table 159. Sirtex Medical Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Sirtex Medical Limited Latest Developments
Table 161. Boston Scientific Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 162. Boston Scientific Corporation Radiotheranostic Product Offered
Table 163. Boston Scientific Corporation Main Business
Table 164. Boston Scientific Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. Boston Scientific Corporation Latest Developments
Table 166. Nihon Medi-Physics Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 167. Nihon Medi-Physics Radiotheranostic Product Offered
Table 168. Nihon Medi-Physics Main Business
Table 169. Nihon Medi-Physics Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 170. Nihon Medi-Physics Latest Developments
LIST OF FIGURES
Figure 1. Radiotheranostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiotheranostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radiotheranostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radiotheranostic Sales Market Share by Country/Region (2022)
Figure 8. Radiotheranostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radiotheranostic Market Size Market Share by Type in 2022
Figure 10. Radiotheranostic in Oncology
Figure 11. Global Radiotheranostic Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Radiotheranostic in Non-Oncology
Figure 13. Global Radiotheranostic Market: Non-Oncology (2018-2023) & ($ Millions)
Figure 14. Global Radiotheranostic Market Size Market Share by Application in 2022
Figure 15. Global Radiotheranostic Revenue Market Share by Player in 2022
Figure 16. Global Radiotheranostic Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 18. APAC Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 19. Europe Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 21. Americas Radiotheranostic Value Market Share by Country in 2022
Figure 22. United States Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Radiotheranostic Market Size Market Share by Region in 2022
Figure 27. APAC Radiotheranostic Market Size Market Share by Type in 2022
Figure 28. APAC Radiotheranostic Market Size Market Share by Application in 2022
Figure 29. China Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Radiotheranostic Market Size Market Share by Country in 2022
Figure 36. Europe Radiotheranostic Market Size Market Share by Type (2018-2023)
Figure 37. Europe Radiotheranostic Market Size Market Share by Application (2018-2023)
Figure 38. Germany Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 52. APAC Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 53. Europe Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 55. United States Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 56. Canada Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 59. China Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 60. Japan Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 61. Korea Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 63. India Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 64. Australia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 65. Germany Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 66. France Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 67. UK Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 68. Italy Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 69. Russia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 70. Spain Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 73. Israel Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 76. Global Radiotheranostic Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Radiotheranostic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Radiotheranostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiotheranostic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radiotheranostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radiotheranostic Sales Market Share by Country/Region (2022)
Figure 8. Radiotheranostic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radiotheranostic Market Size Market Share by Type in 2022
Figure 10. Radiotheranostic in Oncology
Figure 11. Global Radiotheranostic Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Radiotheranostic in Non-Oncology
Figure 13. Global Radiotheranostic Market: Non-Oncology (2018-2023) & ($ Millions)
Figure 14. Global Radiotheranostic Market Size Market Share by Application in 2022
Figure 15. Global Radiotheranostic Revenue Market Share by Player in 2022
Figure 16. Global Radiotheranostic Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 18. APAC Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 19. Europe Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Radiotheranostic Market Size 2018-2023 ($ Millions)
Figure 21. Americas Radiotheranostic Value Market Share by Country in 2022
Figure 22. United States Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Radiotheranostic Market Size Market Share by Region in 2022
Figure 27. APAC Radiotheranostic Market Size Market Share by Type in 2022
Figure 28. APAC Radiotheranostic Market Size Market Share by Application in 2022
Figure 29. China Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Radiotheranostic Market Size Market Share by Country in 2022
Figure 36. Europe Radiotheranostic Market Size Market Share by Type (2018-2023)
Figure 37. Europe Radiotheranostic Market Size Market Share by Application (2018-2023)
Figure 38. Germany Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Radiotheranostic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 52. APAC Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 53. Europe Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 55. United States Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 56. Canada Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 59. China Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 60. Japan Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 61. Korea Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 63. India Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 64. Australia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 65. Germany Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 66. France Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 67. UK Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 68. Italy Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 69. Russia Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 70. Spain Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 73. Israel Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Radiotheranostic Market Size 2024-2029 ($ Millions)
Figure 76. Global Radiotheranostic Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Radiotheranostic Market Size Market Share Forecast by Application (2024-2029)
